BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20591429)

  • 1. S100 proteins interact with the N-terminal domain of MDM2.
    van Dieck J; Lum JK; Teufel DP; Fersht AR
    FEBS Lett; 2010 Aug; 584(15):3269-74. PubMed ID: 20591429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A1 blocks the interaction between p53 and mdm2 and decreases cell proliferation activity.
    Dowarha D; Chou RH; Yu C
    PLoS One; 2020; 15(6):e0234152. PubMed ID: 32497081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53.
    van Dieck J; Teufel DP; Jaulent AM; Fernandez-Fernandez MR; Rutherford TJ; Wyslouch-Cieszynska A; Fersht AR
    J Mol Biol; 2009 Dec; 394(5):922-30. PubMed ID: 19819244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers.
    van Dieck J; Fernandez-Fernandez MR; Veprintsev DB; Fersht AR
    J Biol Chem; 2009 May; 284(20):13804-13811. PubMed ID: 19297317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Members of the S100 family bind p53 in two distinct ways.
    Fernandez-Fernandez MR; Rutherford TJ; Fersht AR
    Protein Sci; 2008 Oct; 17(10):1663-70. PubMed ID: 18694925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73.
    van Dieck J; Brandt T; Teufel DP; Veprintsev DB; Joerger AC; Fersht AR
    Oncogene; 2010 Apr; 29(14):2024-35. PubMed ID: 20140014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mdm2 facilitates the association of p53 with the proteasome.
    Kulikov R; Letienne J; Kaur M; Grossman SR; Arts J; Blattner C
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10038-43. PubMed ID: 20479273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C terminus of p53 binds the N-terminal domain of MDM2.
    Poyurovsky MV; Katz C; Laptenko O; Beckerman R; Lokshin M; Ahn J; Byeon IJ; Gabizon R; Mattia M; Zupnick A; Brown LM; Friedler A; Prives C
    Nat Struct Mol Biol; 2010 Aug; 17(8):982-9. PubMed ID: 20639885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
    Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z
    Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural details on mdm2-p53 interaction.
    Chi SW; Lee SH; Kim DH; Ahn MJ; Kim JS; Woo JY; Torizawa T; Kainosho M; Han KH
    J Biol Chem; 2005 Nov; 280(46):38795-802. PubMed ID: 16159876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 protein-mediated ubiquitination of numb protein: identification of a second physiological substrate of MDM2 that employs a dual-site docking mechanism.
    Sczaniecka M; Gladstone K; Pettersson S; McLaren L; Huart AS; Wallace M
    J Biol Chem; 2012 Apr; 287(17):14052-68. PubMed ID: 22337874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis.
    Fraser JA; Worrall EG; Lin Y; Landre V; Pettersson S; Blackburn E; Walkinshaw M; Muller P; Vojtesek B; Ball K; Hupp TR
    J Mol Biol; 2015 Apr; 427(8):1728-47. PubMed ID: 25543083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time surface plasmon resonance monitoring of site-specific phosphorylation of p53 protein and its interaction with MDM2 protein.
    Wu L; He Y; Hu Y; Lu H; Cao Z; Yi X; Wang J
    Analyst; 2019 Oct; 144(20):6033-6040. PubMed ID: 31502598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interaction between S100A1 and MDM2 may modulate p53 signaling in normal and malignant endometrial cells.
    Nakagawa M; Higuchi S; Hashimura M; Oguri Y; Matsumoto T; Yokoi A; Ishibashi Y; Ito T; Saegusa M
    BMC Cancer; 2022 Feb; 22(1):184. PubMed ID: 35177036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B.
    Wilder PT; Lin J; Bair CL; Charpentier TH; Yang D; Liriano M; Varney KM; Lee A; Oppenheim AB; Adhya S; Carrier F; Weber DJ
    Biochim Biophys Acta; 2006 Nov; 1763(11):1284-97. PubMed ID: 17010455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosomal protein S3: A multi-functional protein that interacts with both p53 and MDM2 through its KH domain.
    Yadavilli S; Mayo LD; Higgins M; Lain S; Hegde V; Deutsch WA
    DNA Repair (Amst); 2009 Oct; 8(10):1215-24. PubMed ID: 19656744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A site-directed mutagenesis study of the MdmX RING domain.
    Egorova O; Mis M; Sheng Y
    Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
    Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
    Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.
    Wang L; He G; Zhang P; Wang X; Jiang M; Yu L
    Mol Biol Rep; 2011 Jan; 38(1):229-36. PubMed ID: 20333547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site.
    Ma J; Martin JD; Xue Y; Lor LA; Kennedy-Wilson KM; Sinnamon RH; Ho TF; Zhang G; Schwartz B; Tummino PJ; Lai Z
    Arch Biochem Biophys; 2010 Nov; 503(2):207-12. PubMed ID: 20816748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.